Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
TANG CAPITAL MANAGEMENT LLC (CIK 1232621) reported $1.97B across 51 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: AUPH ($181.2M, 9.20%), CELC ($119.8M, 6.09%), MIRM ($114.2M, 5.80%), GLPG ($113.6M, 5.77%), SPY ($109.3M, 5.55%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | AUPH | AURINIA PHARMACEUTICALS INC | $181.2M | 9.20% | 12.2M | Added |
| 2 | CELC | CELCUITY INC | $119.8M | 6.09% | 1.1M | Hold |
| 3 | MIRM | MIRUM PHARMACEUTICALS INC | $114.2M | 5.80% | 1.2M | Hold |
| 4 | GLPG | GALAPAGOS NV | $113.6M | 5.77% | 3.8M | Trimmed |
| 5 | SPY | STATE STR SPDR S&P 500 ETF T | $109.3M | 5.55% | 168,000 | Added |
| 6 | KNSA | KINIKSA PHARMACEUTICALS INTL | $108.8M | 5.53% | 2.3M | Hold |
| 7 | CAPR | CAPRICOR THERAPEUTICS INC | $103.4M | 5.25% | 3.4M | Added |
| 8 | PTCT | PTC THERAPEUTICS INC | $102.2M | 5.19% | 1.5M | Hold |
| 9 | SYRE | SPYRE THERAPEUTICS INC | $95.4M | 4.85% | 1.9M | Hold |
| 10 | KALV | KALVISTA PHARMACEUTICALS INC | $92.1M | 4.68% | 4.6M | Hold |
| 11 | CMPX | COMPASS THERAPEUTICS INC | $88.8M | 4.51% | 16.8M | Hold |
| 12 | TARS | TARSUS PHARMACEUTICALS INC | $83.4M | 4.23% | 1.2M | Hold |
| 13 | IMCR | IMMUNOCORE HLDGS PLC | $79.9M | 4.06% | 2.6M | Added |
| 14 | ANAB | ANAPTYSBIO INC | $73.8M | 3.75% | 1.3M | Trimmed |
| 15 | CORT | CORCEPT THERAPEUTICS INC | $60.5M | 3.07% | 1.5M | Added |
| 16 | ANIP | ANI PHARMACEUTICALS INC | $54.4M | 2.76% | 707,500 | Added |
| 17 | INSM | INSMED INC | $42.5M | 2.16% | 260,000 | Added |
| 18 | BNTX | BIONTECH SE | $41.8M | 2.12% | 470,000 | Hold |
| 19 | VRDN | VIRIDIAN THERAPEUTICS INC | $35.1M | 1.78% | 1.8M | Hold |
| 20 | AVIR | ATEA PHARMACEUTICALS INC | $25.9M | 1.32% | 4.8M | Hold |
| 21 | PGEN | PRECIGEN INC | $24.8M | 1.26% | 6.4M | Added |
| 22 | DNTH | DIANTHUS THERAPEUTICS INC | $22.2M | 1.13% | 264,692 | Hold |
| 23 | CMPS | COMPASS PATHWAYS PLC | $22.1M | 1.12% | 4.0M | New |
| 24 | CBIO | CRESCENT BIOPHARMA INC. | $21.3M | 1.08% | 1.2M | Added |
| 25 | STOK | STOKE THERAPEUTICS INC | $16.3M | 0.83% | 500,000 | Hold |
Source: SEC Form 13F filings · as of 2026-03-31